Subcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis Patients
Abstract
Background: We investigated the efficacy, safety and tolerability of once-monthly administration of C.E.R.A. in erythropoiesis stimulating agents (ESAs) naive predialysis patients with CKD for anemia treatment
